Marshall Wace North America’s Claritev Corp CTEV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$786K Buy
3,492
+2,496
+251% +$675K ﹤0.01% 1002
2021
Q2
$379K Buy
996
+204
+26% +$63.2K ﹤0.01% 1236
2021
Q1
$176K Buy
+792
New +$228K ﹤0.01% 1420
2020
Q4
Sell
-3,429
Closed -$1.41M 1640
2020
Q3
$1.41M Buy
+3,429
New +$1.51M 0.01% 702

Other funds holding CTEV

Marshall Wace North America's CTEV Position: Q3 2021 in Review

Marshall Wace North America increased its Claritev Corp (CTEV) stake by 251% in Q3 2021, buying an estimated $675K and bringing the position to 3,492 shares worth $786K. The position accounts for ﹤0.01% of the portfolio, ranked #1002.

Marshall Wace North America first reported a position in CTEV in Q3 2020 and has held it in 4 quarters since. The position peaked at $1.41M in Q3 2020. 128 funds tracked by Wall St. Rank hold CTEV as of Q3 2021.

  • Marshall Wace North America held 3,492 shares of Claritev Corp worth $786K as of Q3 2021.
  • Marshall Wace North America bought 2,496 Claritev Corp shares in Q3 2021, an estimated $675K.
  • Claritev Corp made up ﹤0.01% of Marshall Wace North America's portfolio in Q3 2021, its #1002 holding.
  • Marshall Wace North America first reported a position in Claritev Corp in Q3 2020 and has held it in 4 quarters since.
  • Marshall Wace North America's Claritev Corp position peaked at $1.41M in Q3 2020.
  • 128 funds tracked by Wall St. Rank held Claritev Corp as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.